Updated: January 17, 2026
Alternatives to Bromocriptine If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Alternatives for Hyperprolactinemia and Prolactinomas
- Cabergoline (Dostinex)
- Alternatives for Parkinson's Disease
- Pramipexole (Mirapex)
- Ropinirole (Requip)
- Rotigotine Patch (Neupro)
- Carbidopa/Levodopa (Sinemet)
- Alternatives for Acromegaly
- Alternatives for Type 2 Diabetes (Cycloset)
- The Bottom Line on Alternatives
If bromocriptine is unavailable or not working well for you, several alternatives exist depending on your condition. Here's what to discuss with your doctor.
When bromocriptine is difficult to find, doesn't work well for you, or causes intolerable side effects, your prescriber has options. The right alternative depends entirely on which condition you're treating — since bromocriptine is used for several very different medical problems. This guide covers the most common alternatives for each indication. Always consult your prescriber before making any changes.
Alternatives for Hyperprolactinemia and Prolactinomas
For patients with high prolactin levels, amenorrhea, infertility, galactorrhea, or prolactin-secreting pituitary tumors, bromocriptine was historically the first-line treatment. Today, cabergoline (Dostinex) is widely considered the preferred dopamine agonist for hyperprolactinemia by most clinical guidelines.
Cabergoline (Dostinex)
Dosing: Once or twice weekly (vs. daily or multiple times daily for bromocriptine)
Efficacy: Studies show cabergoline is significantly more effective at normalizing prolactin levels and restoring menstrual cycles
Tolerability: Causes less nausea than bromocriptine; generally better tolerated
Cost: More expensive than generic bromocriptine; generic cabergoline is available and typically $20-$60/month with coupons
Note: Some studies suggest cabergoline may carry a slightly higher risk of cardiac valve regurgitation at high doses; discuss with your cardiologist if you have pre-existing valve disease
For most patients with hyperprolactinemia, cabergoline is considered the gold standard. If you can't access bromocriptine, it is very likely your prescriber will switch you to cabergoline.
Alternatives for Parkinson's Disease
Bromocriptine is rarely a first-line choice for Parkinson's disease today. Current clinical guidelines generally favor non-ergot dopamine agonists, which have a better safety profile (lower risk of fibrosis). If you are on bromocriptine for Parkinson's, your neurologist may already have considered the following alternatives:
Pramipexole (Mirapex)
A non-ergot dopamine agonist targeting D2 and D3 receptors. Available in immediate-release and extended-release formulations. One of the most frequently prescribed dopamine agonists for Parkinson's in the U.S. Generic is widely available and affordable. Can cause daytime sleepiness and impulse control issues.
Ropinirole (Requip)
Another non-ergot dopamine agonist with a similar receptor profile to pramipexole. Available in immediate-release (multiple daily doses) and extended-release (once daily) formulations. Widely used for both Parkinson's disease and restless legs syndrome. Generic is readily available.
Rotigotine Patch (Neupro)
A transdermal patch delivering continuous rotigotine throughout the day. Particularly useful for patients who have swallowing difficulties or who need a consistent delivery method without peaks and valleys. More expensive, but generic versions are now available.
Carbidopa/Levodopa (Sinemet)
For more advanced Parkinson's, carbidopa/levodopa remains the cornerstone of therapy. Bromocriptine is sometimes used as an adjunct to levodopa; if bromocriptine is unavailable, your neurologist may adjust your levodopa regimen temporarily.
Alternatives for Acromegaly
Bromocriptine is not typically the first-line treatment for acromegaly today. Somatostatin analogs — such as octreotide (Sandostatin) and lanreotide (Somatuline Depot) — are generally preferred for their superior efficacy in lowering growth hormone levels. Your endocrinologist would determine the appropriate alternative. Surgery (transsphenoidal resection) remains a primary option for appropriate candidates.
Alternatives for Type 2 Diabetes (Cycloset)
Cycloset (bromocriptine quick-release) is used as an add-on therapy for type 2 diabetes. It is not a first-line medication, and it works through a unique mechanism unlike any other diabetes drug. If Cycloset is unavailable, your diabetes provider will likely add or adjust another glucose-lowering medication from a different class — such as an SGLT2 inhibitor (empagliflozin, dapagliflozin), a GLP-1 receptor agonist (semaglutide, dulaglutide), a DPP-4 inhibitor (sitagliptin), or a sulfonylurea.
The Bottom Line on Alternatives
Before switching medications, it's worth trying to locate your bromocriptine prescription. Our guide on finding bromocriptine in stock covers the best approaches, or you can use medfinder to have us call pharmacies near you. If bromocriptine remains consistently unavailable or is not meeting your treatment goals, the alternatives above are all well-established options — just make sure the switch is made under medical supervision.
Frequently Asked Questions
Cabergoline (Dostinex) is considered the preferred dopamine agonist for hyperprolactinemia by most clinical guidelines. It requires only once- or twice-weekly dosing, is more effective at normalizing prolactin levels than bromocriptine, and causes less nausea. Generic cabergoline is available in the U.S.
No. Switching dopamine agonists requires medical supervision. Your doctor will determine the appropriate dose and timing of the switch based on your prolactin levels, condition severity, and other medications. Never stop or switch bromocriptine without consulting your prescriber first.
No. As of 2026, there is no therapeutically equivalent generic for Cycloset in the United States. If Cycloset is unavailable or unaffordable, your diabetes provider can add an alternative blood sugar-lowering medication from a different drug class.
Non-ergot dopamine agonists — pramipexole (Mirapex) and ropinirole (Requip) — are the preferred choices for Parkinson's disease today. They have a lower risk of fibrotic complications than ergot-derived agents like bromocriptine, and both are available as affordable generics.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Bromocriptine also looked for:
More about Bromocriptine
32,996 have already found their meds with Medfinder.
Start your search today.





